Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.
2.
3.

Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial.

Curtis JR, Westfall AO, Allison J, Becker A, Melton ME, Freeman A, Kiefe CI, MacArthur M, Ockershausen T, Stewart E, Weissman N, Saag KG.

Arch Intern Med. 2007 Mar 26;167(6):591-6.

PMID:
17389291
4.

Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement.

Solomon DH, Katz JN, Cabral D, Patrick AR, Bukowski JF, Coblyn JS.

Arthritis Rheum. 2006 Dec 15;55(6):873-7.

5.

Barriers in the management of glucocorticoid-induced osteoporosis.

Guzman-Clark JR, Fang MA, Sehl ME, Traylor L, Hahn TJ.

Arthritis Rheum. 2007 Feb 15;57(1):140-6.

6.

Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting.

Yood RA, Harrold LR, Fish L, Cernieux J, Emani S, Conboy E, Gurwitz JH.

Arch Intern Med. 2001 May 28;161(10):1322-7.

PMID:
11371261
7.

Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.

Ledwich LJ, Clarke K.

J Clin Rheumatol. 2009 Mar;15(2):61-4. doi: 10.1097/RHU.0b013e31819b65bd.

PMID:
19265346
9.

Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumatologists in a Latin-American city.

Caballero-Uribe CV, Acosta-Velez JG, Hernandez-Ruiz EA, Andrade Rodado FM, PeƱuela-Epalza M.

J Clin Rheumatol. 2008 Jun;14(3):153-5. doi: 10.1097/RHU.0b013e31816b1931.

PMID:
18525434
10.

Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.

Stoch SA, Saag KG, Greenwald M, Sebba AI, Cohen S, Verbruggen N, Giezek H, West J, Schnitzer TJ.

J Rheumatol. 2009 Aug;36(8):1705-14. doi: 10.3899/jrheum.081207. Epub 2009 Jun 1.

PMID:
19487264
11.

Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients.

Curtis JR, Westfall AO, Allison JJ, Becker A, Casebeer L, Freeman A, Spettell CM, Weissman NW, Wilke S, Saag KG.

Arthritis Rheum. 2005 Aug;52(8):2485-94.

12.

Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in Science.

Abadie EC, Devogealer JP, Ringe JD, Ethgen DJ, Bouvenot GM, Kreutz G, Laslop A, Orloff JJ, Vanderauwera PM, Delmas PD, Dere WH, Branco J, Altman RD, Avouac BP, Menkes CJ, Vanhaelst L, Mitlak BH, Tsouderos Y, Reginster JY.

Semin Arthritis Rheum. 2005 Aug;35(1):1-4. Review.

PMID:
16084217
13.

Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.

De Nijs RN.

Minerva Med. 2008 Feb;99(1):23-43. Review.

PMID:
18299694
14.

Current use of glucocorticoids in patients with rheumatoid arthritis in Germany.

Thiele K, Buttgereit F, Huscher D, Zink A; German Collaborative Arthritis Centres.

Arthritis Rheum. 2005 Oct 15;53(5):740-7.

15.

Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.

Cruse LM, Valeriano J, Vasey FB, Carter JD.

J Clin Rheumatol. 2006 Oct;12(5):221-5.

PMID:
17023807
16.

A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture.

Majumdar SR, Rowe BH, Folk D, Johnson JA, Holroyd BH, Morrish DW, Maksymowych WP, Steiner IP, Harley CH, Wirzba BJ, Hanley DA, Blitz S, Russell AS.

Ann Intern Med. 2004 Sep 7;141(5):366-73.

PMID:
15353428
17.

Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008).

Majumdar SR, Lix LM, Yogendran M, Morin SN, Metge CJ, Leslie WD.

J Clin Endocrinol Metab. 2012 Apr;97(4):1236-42. doi: 10.1210/jc.2011-2645. Epub 2012 Feb 1.

PMID:
22298803
18.
19.

What is new in the treatment of steroid-induced osteoporosis?

Liu RH, Werth VP.

Semin Cutan Med Surg. 2006 Jun;25(2):72-8. Review.

PMID:
16908396
20.

Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics.

Solomon DH, Brookhart MA, Gandhi TK, Karson A, Gharib S, Orav EJ, Shaykevich S, Licari A, Cabral D, Bates DW.

Am J Med. 2004 Dec 15;117(12):919-24.

PMID:
15629730

Supplemental Content

Support Center